Data Foundry

Drug recalls 2020

Maximum Strength Lidocaine Cold & Hot Patch — Class II drug recall D-1280-2020

Ongoing recall by Wuhan Bingbing Pharmaceutical Co., Ltd., reported 2020-06-03, distributed nationwide. CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assu

Recall numberD-1280-2020
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmWuhan Bingbing Pharmaceutical Co., Ltd., Wuhan, N/A, China
Recall initiated2020-05-19
Classified2020-05-28
Reported by FDA2020-06-03
DistributedNationwide (US)
Quantity72,600 boxes
Reason classeslabeling, cgmp
NDC66902-0218-05
Lot numbers170614, 180108, 180109, 180110, 180111, 180112, 180113, 180317, 180318, 2020.06.13, 2021.01.07, 2021.01.08, 2021.01.09, 2021.01.10, 2021.01.11, 2021.01.12, 2021.03.16, 2021.03.17

Product

Maximum Strength Lidocaine Cold & Hot Patch (lidocaine 4%, menthol 1%), 5 patches per box, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895; NDC 66902-218-05.

Reason for recall

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1280-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.